GlassScriptPhysician profile
Alexandra L Springman
NPI 1720647332
$282.23
in general payments reported to CMS, 2019-2025
10 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.23 · 2023: $29.84 · 2024: $40.84 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $70.59 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Seqirus USA INC | $45.66 | 2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $38.46 | 2025 | |
| Supernus Pharmaceuticals, INC. | $26.15 | 2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $23.32 | 2022 | |
| Sanofi Pasteur INC. | $22.00 | 2025 | |
| Verrica Pharmaceuticals INC. | $14.51 | 2023 | Ycanth |
| Pfizer INC. | $14.34 | 2022 | |
| Collegium Pharmaceutical, INC. | $13.63 | 2025 | Jornay Pm |
| Kaleo, INC. | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Springman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.